Serotype distribution, antibiotic resistance and clonality of streptococcus pneumoniae isolated from immunocompromised patients in Tunisia

Anis Raddaoui, Alexandra S. Simoes, Rekaya Baaboura, Sofia Felix, Wafa Achour, Tarek Ben Othman, Mohamed Bejaoui, Raquel Sa-Leao, Assia Ben Hassen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Pneumococcal disease, a major cause of morbidity and mortality globally, has higher incidence among young children, the elderly and the immunocompromised of all ages. In Tunisia, pneumococcal conjugate vaccines (PCVs) are not included in the national immunization program. Also, few studies have described the epidemiology of S. pneumoniae in this country and, in particular, no molecular typing studies have been performed. The aim of this study was to evaluate serotype distribution, antimicrobial resistance and clonality of Streptococcus pneumoniae isolated from neutropenic patients in Tunisia. Methods Fifty-nine S. pneumoniae were isolated from infection (n = 31) and colonization (n = 28) sites of patients (children and adults) attending the National Centre of Bone Marrow Transplantation in Tunis between 2005-2011. All isolates were characterized by serotype, antimicrobial resistance pattern and multilocus sequence typing (MLST). Results The majority (66.1%) of the isolates belonged to five serotypes all included in PCVs: 6B, 9V, 14, 19F and 23F. The potential coverage of the 10-valent and 13-valent PCV was of 71.2% and 76.3% respectively. Resistance rates were very high and 69.5% of the isolates were multidrug resistant: non-susceptibility rates to penicillin, amoxicillin and cefotaxime were 66.1%, 40.7%and 27.1%, respectively; resistance rates to erythromycin, clindamycin, tetracycline, chloramphenicol and trimethoprim-sulfamethoxazole, were 69.5%, 61.0%, 37.3%, 22.0% and 67.8%, respectively. The most frequent serotypes had STs characteristic of multidrug resistant international clones known to be highly successful and important causes of pneumococcal infection: Spain 23F-ST81, France 9V/14-ST156, Spain 6B-ST90, 19FST320, and Portugal 19F-ST177. Conclusions The majority of S. pneumoniae strains recovered from immunocompromised patients in Tunisia are representatives of multidrug resistant pandemic clones that express serotypes targeted by PCVs. To contain the burden of pneumococcal disease and improve treatment choices among Tunisian immunocompromised patients PCVs should be offered to all of them.

Original languageEnglish
Article numbere0140390
JournalPlosOne
Volume10
Issue number10
DOIs
Publication statusPublished - 13 Oct 2015

Fingerprint Dive into the research topics of 'Serotype distribution, antibiotic resistance and clonality of streptococcus pneumoniae isolated from immunocompromised patients in Tunisia'. Together they form a unique fingerprint.

  • Cite this

    Raddaoui, A., Simoes, A. S., Baaboura, R., Felix, S., Achour, W., Othman, T. B., ... Hassen, A. B. (2015). Serotype distribution, antibiotic resistance and clonality of streptococcus pneumoniae isolated from immunocompromised patients in Tunisia. PlosOne, 10(10), [e0140390]. https://doi.org/10.1371/journal.pone.0140390